IL18 and metabolic syndrome: For instance, IL-18, the designated marker of NLRP3 inflammasome activation status was decreased by 43% in men and women with metabolic syndrome in response to a 12-week aerobic interval training program (three times a week) (Stensvold et al., 2012).